findmyKOL
Clinical trialNCT00006223CompletedPhase 3Interventional

flt3L in Treating Patients With Acute Myeloid Leukemia

SponsorEastern Cooperative Oncology GroupLeukemia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Drugs such as flt3L may stimulate a person's immune system and help kill cancer cells. It is not yet known if flt3L is effective in treating acute myeloid leukemia. PURPOSE: Randomized phase III trial to determine the effectiveness of flt3L in treating patients who have acute myeloid leukemia that is in remission.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Veterans Affairs Medical Center - Birmingham

    Birmingham, Alabama, United States

  • University of California San Diego Cancer Center

    La Jolla, California, United States

  • Ucsf Cancer Center and Cancer Research Institute

    San Francisco, California, United States

  • Veterans Affairs Medical Center - San Francisco

    San Francisco, California, United States

  • Ccop - Christiana Care Health Services

    Wilmington, Delaware, United States

  • Lombardi Cancer Center

    Washington D.C., District of Columbia, United States

  • Walter Reed Army Medical Center

    Washington D.C., District of Columbia, United States

  • Ccop - Mount Sinai Medical Center

    Miami Beach, Florida, United States

  • University of Chicago Cancer Research Center

    Chicago, Illinois, United States

  • Veterans Affairs Medical Center - Chicago (westside Hospital)

    Chicago, Illinois, United States

  • Holden Comprehensive Cancer Center at the University of Iowa

    Iowa City, Iowa, United States

  • Veterans Affairs Medical Center - Togus

    Togus, Maine, United States

  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland

    Baltimore, Maryland, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • University of Massachusetts Memorial Medical Center

    Worcester, Massachusetts, United States

  • University of Minnesota Cancer Center

    Minneapolis, Minnesota, United States

  • Veterans Affairs Medical Center - Minneapolis

    Minneapolis, Minnesota, United States

  • Ellis Fischel Cancer Center - Columbia

    Columbia, Missouri, United States

  • Veterans Affairs Medical Center - Columbia (truman Memorial)

    Columbia, Missouri, United States

  • Barnes-Jewish Hospital

    St Louis, Missouri, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

  • Ccop - Southern Nevada Cancer Research Foundation

    Las Vegas, Nevada, United States

  • Norris Cotton Cancer Center

    Lebanon, New Hampshire, United States

  • Roswell Park Cancer Institute

    Buffalo, New York, United States

  • Veterans Affairs Medical Center - Buffalo

    Buffalo, New York, United States

  • Ccop - North Shore University Hospital

    Manhasset, New York, United States

  • Schneider Children'S Hospital at North Shore

    Manhasset, New York, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • Mount Sinai Medical Center, Ny

    New York, New York, United States

  • New York Presbyterian Hospital - Cornell Campus

    New York, New York, United States

  • Ccop - Syracuse Hematology-Oncology Associates of Central New York, P.C.

    Syracuse, New York, United States

  • State University of New York - Upstate Medical University

    Syracuse, New York, United States

  • Veterans Affairs Medical Center - Syracuse

    Syracuse, New York, United States

  • Lineberger Comprehensive Cancer Center, Unc

    Chapel Hill, North Carolina, United States

  • Duke Comprehensive Cancer Center

    Durham, North Carolina, United States

  • Veterans Affairs Medical Center - Durham

    Durham, North Carolina, United States

  • Ccop - Southeast Cancer Control Consortium

    Winston-Salem, North Carolina, United States

  • Comprehensive Cancer Center at Wake Forest University

    Winston-Salem, North Carolina, United States

  • Arthur G. James Cancer Hospital - Ohio State University

    Columbus, Ohio, United States

  • Rhode Island Hospital

    Providence, Rhode Island, United States

7 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Recombinant flt3 ligand
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2000
Primary completion
—
Completion
31 Jan 2007
Last update posted
24 Jun 2013
Registered enrollment
—
Registry id
NCT00006223

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.